Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients

Psychoneuroendocrinology

Volumn 26, Issue 1, 2001, Pages 65-76

  Schuld, Andreas ^a   Kraus, Thomas ^a   Haack, Monika ^a   Hinze Selch, Dunja ^a   Zobel, Astrid W ^a   Holsboer, Florian ^a   Pollmächer, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Colony stimulating factors; Glucocorticoids; Granulocytes; Hypothalamus pituitary adrenal axis; Interleukins; Tumor necrosis factor

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DEPRESSION; DISEASE SEVERITY; FEMALE; GRANULOCYTE; HORMONAL REGULATION; HOST RESISTANCE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MONOCYTE; PRIORITY JOURNAL; PROVOCATION TEST;

ADRENAL GLANDS; ADULT; AGED; AGED, 80 AND OVER; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; DEPRESSION; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035218786     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(00)00039-1     Document Type: Article

References (27)

1. The potential biological and clinical significance of the soluble tumor necrosis factor receptors
2. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals
3. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man
4. Modulation of glucocorticoid receptor gene expression by antidepressant drugs
5. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
6. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice: Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN gamma antibodies
7. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: Neural and immune inputs
8. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
9. Increase in plasma Interleukin-10 following hydrocortisone injection
10. Glucocorticoids as cytokine inhibitors: Role in neuroendocrine control and therapy of inflammatory diseases
11. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis
12. Immunomodulation by colony-stimulating factors
13. A rating scale for depression
14. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
15. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
16. Antidepressants and the hypothalamic-pituitary-adrenocortical regulation
17. Glucocorticoids dose-dependently increase plasma levels of granulocyte colony-stimulating factor in man
18. Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-α suppression
19. Levels of granulocyte colony-stimulating factor in patients with infections
20. Stress, depression and the activation of the immune system
21. Major depression and the activation of the inflammatory response system
22. Development of neutrophilia by serially increasing doses of dexamethasone
23. Dexamethasone inhibits IL-1 and TNF-α activity in human lung fibroblasts without affecting IL-1 or TNF receptors
24. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
25. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals
26. Increased serum human granulocyte colony-stimulating factor (G-CSF) levels following intravenous infusion of high-dose methylprednisolone